expand_more
New Insights on the Impact of IgG4-related Disease
Although ongoing research continues to advance our understanding of IgG4-related disease (IgG4-RD), the epidemiology and downstream consequences of this relatively rare and complex autoimmune ...
Surge in Adoption of the Steritas eCOA Suite Continues
Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
Risk Factors for Steroid-toxicity and Cardiovascular Disease Overlap
A new study published in the New England Journal of Medicine shows the incidence of cardiovascular disease correlates strongly with the four metabolic domains used in the Steritas GTI-MD (body mass ...
Discovering Steroid-toxicity Secrets Concealed in Large Datasets
A challenge that has vexed health systems and payers for decades is the inability to fully quantify the long-term impacts of steroid-toxicity. Set to change that paradigm is the GTI-MD, an ...
Ensuring Data Integrity When the Stakes Are High
When the stakes involve patient outcomes and the credibility of clinical trials in the medical, health and pharmaceutical sectors, maintaining data accuracy, integrity and privacy is essential. In ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
